- CSO -
Grégoire has extensive expertise in ONCOLOGY focusing on Research and Development projects, and has also pioneered Expert Drug Development Education programs in France. Grégoire brings with him 30 years of experience in Oncology research and development.
He obtained his PhD in Molecular and Cellular Biology in 1989 at the Institut Pasteur of Paris (France), and continued his scientific career as a post-doctorate at IOCMH (Bobigny, France) and BIOMEASURE (Milford, MA, USA). In 1995, he was appointed as Oncology Research Leader at Beaufour-IPSEN (Les Ulis, France) and held progressive positions at IPSEN, among which Oncology Translational Research Director, Oncology Scientific Affairs Global Director and member of the Oncology Portfolio Management Team.
He has participated in the transfer of 3 drug candidates to the clinic and has been a significant contributor to the Oncology field with more than 100 scientific publications and patent families. In March 2011, Grégoire joined InteRNA Technologies (Utrecht, The Netherlands) as Chief Development Officer and in 2013 joined OREGONTherapeutics as Chief Scientific Officer to support Oregon’s R&D Oncology projects. In addition in 2012, he co-founded the Sino-French School of Oncology in China with Professor Jianfeng Liu from HUST.